Plaintiffs allege the companies misled consumers about the risks associated with the drugs, including potential side effects and safety concerns
During the initial week, your body is adjusting to the introduction of the hormone mimic
GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis
Wegovy (semaglutide) is a GLP-1 receptor agonist that reduces appetite, increases satiety, and delays gastric emptying to support weight loss
It contains semaglutide in its base form and is manufactured under strict quality controls
Last reviewed: July 1, 2026 Last updated: July 1, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations